Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
This distinction may explain the discrepancy between our findings and those of the recently presented STOP (Semaglutide Treatment Effect On Coronary Atherosclerosis Progression In Diabetes) trial, which assessed non-calcified PV progression via CCTA in 140 T2D patients with chronic atherosclerotic disease and failed to demonstrate the superiority of semaglutide over placebo [31]
The product is supplied in lyophilized powder form to support stability and integrity during storage and handling
2013 Nov;37(11):1514
Li T, Fu C, Tang Z, Li C, Hua D, Liu B, et al
US$ 25.85
US$ 27.49
US$ 26.01
US$ 23.64
US$ 26.48
US$ 20.04
